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Abstract
Background: Human heparanase plays an important role in cancer development and single nucleotide polymorphisms
(SNPs) in the heparanase gene (HPSE) have been shown to be correlated with gastric cancer. The present study examined
the associations between individual SNPs or haplotypes in HPSE and susceptibility, clinicopathological parameters and
prognosis of gastric cancer in a large sample of the Han population in northern China.
Methodology/Principal Findings: Genomic DNA was extracted from formalin-fixed, paraffin-embedded normal gastric
tissue samples from 404 patients and from blood from 404 healthy controls. Six SNPs were genotyped by matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry. A chi-square (x2) test and unconditional logistic regression
were used to analyze the risk of gastric cancer; a Log-rank test and Cox proportional hazards model were used to produce
survival analysis and a Kaplan-Meier method was used to map survival curves. The mean genotyping success rates were
more than 99% in both groups. Haplotype CA in the block composed of rs11099592 and rs4693608 had a greater
distribution in the group of Borrmann types 3 and 4 (P=0.037), the group of a greater number of lymph node metastases
(N3 vs N0 group, P=0.046), and moreover was correlated to poor survival (CG vs CA: HR=0.645, 95%CI: 0.421–0.989,
P=0.044). In addition, genotypes rs4693608 AA and rs4364254 TT were associated with poor survival (P=0.030, HR=1.527,
95%CI: 1.042–2.238 for rs4693608 AA; P=0.013, HR=1.546, 95%CI: 1.096–2.181 for rs4364254 TT). There were no
correlations between individual SNPs or haplotypes and gastric cancer risk.
Conclusions/Significance: A functional haplotype in HPSE was found, which included the important SNP rs4693608. SNPs in
HPSE play an important role in gastric cancer progression and survival, and perhaps may be a molecular marker for
prognosis and treatment values.
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Introduction
Gastric cancer is the fourth most common cancer worldwide
and second leading cause of cancer mortality [1]. Despite
advances in diagnosis and treatment, the prognosis for patients
with advanced gastric cancer remains dismal [2]. Furthermore,
gastric cancer is a disease of gene-environment interactions and
genetic factors play an important role in tumorigenesis and
progression [3]. Therefore, discovery and application of biomark-
ers incorporated with traditional cancer diagnosis, staging, and
prognosis could be considered the best option for controlling this
life-threatening disease [4].
Single nucleotide polymorphisms (SNPs) have been thought to
be attractive biomarkers in cancer risk assessment, screening,
staging, or grading [5]. Also, the human genome is composed of a
series of ‘haplotype blocks’, which are nonrandom associations of
alleles due to linkage disequilibrium (LD) and it is possible to
exploit a vast amount of information considering these haplotype
blocks [6,7]. Although the application of individual SNP analysis
has been limited thus far, haplotype-based association study has
been proposed as a powerful and comprehensive approach to
identify causal genetic variation underlying complex diseases [8,9].
Heparanase is the only known mammalian enzyme that
degrades heparan sulfate (HS) proteoglycans in basement
membranes and the extracellular matrix [10]. This leads to
disassembly of extracellular barriers, release of HS-bound
bioactive factors and generation of HS fragments that promote
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is strongly associated with cancer progression and metastasis,
including cell survival, invasion, proliferation, neovascularization,
and the creation of a growth-permissive microenvironment
[13,14] and it has both prognostic and therapeutic applications
[15]. The heparanase gene (HPSE), first cloned in 1999, is located
on chromosome 4q21.3 [16]. There have been few studies on
SNPs in the HPSE gene. Molecular epidemiologic studies have
shown distribution differences in SNPs in HPSE in various Israeli
Jewish populations [17]. Associations to tumor susceptibility have
also been demonstrated, including hematological malignancies
and gastric cancer, but the results have not been accordant [18–
20]. In addition, Shirley Ralphand [21] has shown an HPSE
haplotype was correlated to stages in ovarian carcinoma and Yue
et al. [20] have shown SNPs were correlated to clinicopathological
parameters and survival rate. Specifically, the study indicated that
SNPs in HPSE were associated with heparanase expression levels
and provided the basis for further studies on the associations
between SNPs and disease [22]. However, these association studies
were limited to small samples.
Recently, Hennig G [23] and Horn H [24] observed high
genotyping detection rates (93.5% and 94–97%) and a perfect
concordance rate of 100% with DNA extracted from normal
formalin-fixed, paraffin-embedded tissues (FFPETs) compared to
germline DNA using matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS). Besides,
other reports also demonstrated high genotyping detection rates
and a perfect concordance rate with FFPET-derived DNA
including decades-old blocks compared to blood from the same
individual using other methods, even in genome-wide genotyping
[25–28]. It has been ascertained that FFPET-derived DNA was
sufficient for genetic polymorphism analysis. In the present study,
we used a large collection of FFPET-derived DNA samples from
patients and blood-derived DNA from controls in a MALDI-TOF
MS method to genotype and study the potential associations
between six SNPs (rs4693602, rs6856901, rs4364254, rs11099592,
rs4693608 and rs4328905) or haplotypes in HPSE and tumor
susceptibility, clinicopathological parameters, and survival of
gastric cancer with a large sample of the Han population in
northern China. As a result, individual SNPs and a haplotype were
found to show associations with the progression and prognosis of
gastric cancer.
Results
Subject characteristics
The average age was 56.67611.923 y and the percentage of
males was 70.54% in the case group. The average age of the
control group was 56.91611.477 y and the percentage of males
was 70.54%. There was no distribution difference in sex and age
between the patients and controls (P=1.00 for both sex and age).
Of the 404 patients, stage I gastric cancer cases accounted for
21.0% (85/404), stage II gastric cancer cases accounted for 26.5%
(107/404) and stage III gastric cancer cases accounted for 52.5%
(212/404) (Table 1).
Genotyping success rates
We used MassArray Typer Analyzer software 4.0.4.20 for
automated spectra processing and genotype identification. Repre-
sentative MALDI-TOF-MS profiles of each genotype of the six
SNPs in HPSE were shown in Figure S1. All the SNPs were
polymorphic with minor allele frequency .10% and genotype
distributions were all in agreement with Hardy-Weinberg
equilibrium (data not shown). High success rates, ranging between
96.29% and 100% (mean: 99.09%) in the FFPETs group and
between 99.50% and 100% (mean: 99.79%) in control group,
were shown (Table S1).
Associations between individual SNPs and
clinicopathological parameters and survival
Allelic frequencies and genotypic frequencies in the six SNPs
were not significantly different between patients and controls
(P.0.05 and P.0.05 after a permutation test for allelic
frequencies; P.0.05 and P.0.05 after being adjusted for sex
and age for genotypic frequencies; Tables S2 and S3).
SNPs were evaluated for associations with the clinicopatholog-
ical parameters. rs4364254 genotypes were associated with
histologic grades (P=0.002; Table S4), genotype TT was
correlated to well cell differentiation compared to the genotype
TC/CC (OR=0.482; 95%CI: 0.300–0.774). Other SNPs had no
significant correlations to clinicopathological parameters.
In univariate analysis, patients carrying the rs4693608 AA
genotype had poor gastric cancer–specific survival compared to
patients with the AG+GG genotype (P=0.049, HR=1.387,
95%CI: 1.001–1.923; Table 2, Figure 1 and Figure S2). In
multivariate analysis, the rs4693608 AA genotype and rs4364254
TT genotype both had a poor gastric cancer–specific survival
(P=0.030, HR=1.527, 95%CI: 1.042–2.238 for rs4693608;
P=0.013, HR=1.546, 95%CI: 1.096–2.181 for rs4364254;
Table 2). Also, Borrmann type (P,0.001), pT category
(P,0.001), pN category(P,0.001), and lymphovascular invasion
(P,0.001) were significantly correlated with survival in univariate
analysis. Borrmann type (P=0.021), pT category (P,0.001), and
pN category (P,0.001) remained significantly correlated with
survival in multivariate analysis (Table 2).
Table 1. Distributions of selected characteristics in gastric
cancer cases and controls (n=404 for both case and control
groups).
Variable
Patients
(n=404)
No. (%)
Controls
(n=404)
No. (%) P*
Sex
Male 285(70.54) 285(70.54) 1.00
Female 119(29.46) 119(29.46)
Age at diagnosis
#40 30 (7.43) 30 (7.43) 1.00
41–50 94(23.27) 94(23.27)
51–60 111(27.48) 111(27.48)
61–70 122(30.20) 122(30.20)
.70 47(11.63) 47(11.63)
Tumor stage at diagnosis
Ia 45(11.1)
Ib 40(9.9)
IIa 58(14.4)
IIb 49(12.1)
IIIa 57(14.1)
IIIb 115(28.5)
IIIc 40(9.9)
IV 0(0)
*Two-sided x
2 test.
doi:10.1371/journal.pone.0030277.t001
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features and survival
There were two two-marker haplotype blocks constructed
between the six SNPs in our results (Figure 2). Block 1 was
composed of rs4693602 and rs6856901 and contained three
common haplotypes (frequency range: 0.025–0.850), which
represented approximately 99.9% of the subjects; block 2 was
composed of rs11099592 and rs4693608 and also contained three
common haplotypes (frequency range: 0.091–0.798), which
represented approximately 99.9% of the subjects. All six common
haplotypes had no correlation with gastric cancer risk (P.0.05 and
P.0.05 after a permutation test; Table S5).
Associations between haplotypes in HPSE and gastric cancer
clinicopathologic features at the time of diagnosis were evaluated.
Haplotype CA in block 2 had greater distribution in the group of
Borrmann types 3 and 4 compared to TG+CG haplotypes
(P=0.037; Table 3). Haplotype distribution differences were
observed in the pN category (P=0.045; Table 3), CA had a
greater distribution in the N3 group than the N0 group compared
to CG (OR=1.837,95%CI: 1.010–3.341, P=0.046), but there
were no significant distribution differences between the N2 and N0
groups and between the N1 and N0 groups (P=0.671 and
P=0.496, respectively).
The haplotypes of block 2 indicated a significant difference in
tumor-related survival. Patients carrying the CA haplotype had a
poor gastric cancer–specific survival (CG vs CA: HR=0.645,
95%CI: 0.421–0.989, P=0.044; Table 4).
Discussion
As we have known, FFPET-derived DNA has lower extraction
efficacy and quality (fragmented DNA) due to partial nucleic acid
cross-linking and degradation than blood-derived DNA. But
archived FFPETs provide an invaluable source for molecular
genetic studies with several advantages such as (i) the only type of
samples available for individuals who cannot otherwise provide a
DNA sample, (ii) an excellent resource for large-scale retrospective
biomarker studies, (iii) a large number of samples conjunct with
long-term clinical follow-up data, (iv) a valuable resource with
diagnosis and histological identification, (v) an available resource
from pathology archives. Recently, FFPET-extracted DNA has
been reported to be adequate for genotyping, and has been
allowed for biomarker and functional genomics studies [23–29].
Table 2. Univariate and multivariate Cox proportional hazard analysis for gastric cancer patients of the six SNPs in HPSE Versus
clinicopathological parameters (n=381).
Univariate Multivariate
Parameter HR 95%CI P HR 95%CI P
Sex Female vs Male 1.138 0.831–1.560 0.420
Age 1.006 0.992–1.019 0.418
pT category 2.289 1.897–2.762 ,0.001
* 1.633 1.305–2.044 ,0.001
*
pN category 2.097 1.813–2.425 ,0.001
* 1.756 1.494–2.062 ,0.001
*
Borrmann type Borr1+2vsBorr3+4 4.283 2.688–6.823 ,0.001
* 1.768 1.099–2.871 0.021
*
Histologic grade well vs poor 1.147 0.807–1.629 0.445
Venous invasion 1.851 0.591–5.793 0.290
Lymphovascular invasion 2.015 1.478–2.748 ,0.001
*
rs4693602 GG vs GA+AA 1.293 0.917–1.825 0.143
rs6856901 CC vs CG+GG 1.294 0.908–1.845 0.153
rs4364254 TT vs TC+CC 1.025 0.766–1.371 0.868 1.546 1.096–2.181 0.013
*
rs11099592 CC vs CT+TT 1.128 0.770–1.652 0.537
rs4693608 AA vs AG+GG 1.387 1.001–1.923 0.049
* 1.527 1.042–2.238 0.030
*
rs4328905 AA vs AG+GG 1.052 0.775–1.427 0.747
*Statistically significant (P,0.05).
Abbreviation: HR, hazard rate; CI, confidence interval.
doi:10.1371/journal.pone.0030277.t002
Figure 1. Kaplan-Meier survival curve analysis with rs4693608
genotypes. Results show that accumulative survival rate of 381 cases
with gastric cancer were associated with the different rs4693608
genotypes in HPSE gene.
doi:10.1371/journal.pone.0030277.g001
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accuracy for SNP genotyping, is currently considered as a gold
standard [29,30]. Genotyping of FFPET-derived DNA by
MALDI-TOF MS has been proven to be reliable and reproduc-
ible. Previously reports showed that there were no allelic frequency
differences between FFPET-derived DNA and blood-derived
DNA from the same individual through several methods including
MALDI-TOF MS [24–26,28]. Our efforts showed high success
rates ranging between 96.29% and 100% (mean: 99.09%), which
were in accordance with previous reported data [23,24,29].
SNPs are stably inherited, highly abundant and show diversity
within and among populations, which are thought to be attractive
biomarkers. However, the application of individual SNPs has been
limited because they are low penetrance and their effects are
relatively difficult to identify [5,31]. Therefore, the importance of
haplotype information has been increasing to link DNA sequence
variation with disease [32]. Articles have reported that functional
SNPs in HPSE were associated with heparanase expression
differences and heparanase has been shown to be closely involved
in the pathological process, progression and outcome of the disease
[10,22]. How to incorporate SNPs, however, in studies about
gastric cancer predisposition and prognosis and how to determine
the true associations are still challenging tasks.
There were no individual SNPs correlated to gastric cancer risk
in our results. The associations between four individual SNPs
(rs4328905, rs4693608, rs11099592 and rs6856901) and gastric
cancer risk with 155 patients and 204 controls reported by Yue et
al. [20] were in accordance with our results. Furthermore, all six
common haplotypes had no significant differences in gastric
cancer risk. This consistency showed SNPs in HPSE had no
correlation to the incidence of gastric cancer in ethnic Han
northern Chinese, not only from the perspective of individual
SNPs, but also from the perspective of haplotypes.
In our present study, genotype rs4364254 TT was correlated to
well cell differentiation. In addition, Ostrovsky et al. [22] found
individuals with genotype TT possessed relatively high mRNA
levels (P=0.0029). However, there have been conflicting results
reported as to associations between heparanase expression and
histological differentiation. Endo K et al. [33] found that
histological differentiation was worse in the heparanase mRNA-
positive gastric cancer tissues (p,0.01). Chen JQ et al. [34] found
that histologic differentiation was not related to heparanase
mRNA expression in gastric cancer (P=1.000). Takaomi Ohkawa
et al. [35] demonstrated that heparanase expression was detected
as stronger in well-differentiated cells (P=0.0277), which is a
finding that consistents with our results. Therefore, heparanase
might be involved in cell differentiation, but the mechanisms are
not clear at present.
In univariate analysis, patients carrying rs4693608 AA genotype
had a poor survival (P=0.049); in multivariate analysis, rs4693608
AA and rs4364254 TT both were significantly correlated with
poor survival (P=0.030 for rs4693608 AA and P=0.013 for
rs4364254 TT). Possibly, the absence of consensus in the
univariate and multivariate analysis was due to the weak effect
of the individual SNP, but when the individual SNP was
considered together with the other SNP, Borrmann type, pT
category, and pN category in multivariate analysis, it generated an
influence on the prognosis. There is ample evidence to suggest that
genetic factors contribute to the disease process in common
complex trait diseases, but the effect of a single variant is probably
small [36]. Besides, Ostrovsky et al. [37] provided a first evidence
of correlation between functional SNPs rs4693608 and rs4364254
and risk of acute graft-versus-host disease (GVHD) development,
and the rs4693608 was the most important. Their results were
accordance to ours. In addition, Ostrovsky et al. [22] reported
both rs4364254 TT genotype and also rs4693608 AA genotype
were correlated to a relatively high mRNA level (P=0.0029 and
0.004, respectively), which might partially explain a worse
prognosis in patients with rs4693608 AA or rs4364254 TT in
the present study. These observations were biologically plausible
because overexpression of HPSE was closely associated with
greater invasiveness of gastric cancer [38–40]. The present results
demonstrated our presumption that SNPs were involved in the
regulation of heparanase expression, thereby affecting invasion
ability and survival in gastric cancer.
Though neither genotype rs11099592 CC nor rs4693608 AA
showed a statistical difference in Borrmann type, haplotype CA
composed with them did show a significant difference. Haplotype
CA had a greater distribution in the group of Borrmann types 3
and 4 (P=0.037). Perhaps patients with haplotype CA were more
likely to develop a poorer general type. Besides, haplotype CA had
a greater distribution in the N3 group (P=0.046, compared to the
N0 group). However, there were no significant distribution
Figure 2. SNPs in the region of the HPSE gene cluster located
on chromosome 4q21. A: HPSE gene structure. Filled boxes
represent the 13 exons (59R39). Arrows show the locations of SNPs.
B: Mapping of the block structure of the six SNPs generated by
Haploview. The value within each square in the triangle plot represents
the pairwise correlation between SNPs (measured as D’) defined by the
upper-left and the upper-right sides of the Squares. The Squares
without a number correspond to D’=1. Shading represents the
magnitude and significance of pairwise LD, with a red-to-white gradient
reflecting higher to lower LD values. The frequency of each common
haplotype within a block is to the side of the haplotype.
doi:10.1371/journal.pone.0030277.g002
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and N0 groups. Perhaps there was an association between
haplotype CA and greater numbers of lymph node metastases,
but it needs further study. Moreover, patients carrying the CA
haplotype also showed poor gastric cancer–specific survival, which
was consistent with the differences in Borrmann type and numbers
of lymph node metastases. Furthermore, Ostrovsky et al. [22]
reported that rs11099592 CC genotype and rs4693608 AA
genotype were correlated to high mRNA expression (P=0.0167
and P=0.004, respectively), which were in accordance with our
results about haplotype CA. Perhaps the absolute risk associated
with each of SNPs was low, but combined haplotype analysis may
be more helpful in identifying individuals at high risk for
progression of the disease. Perhaps it was specific haplotypes that
play a significant role in gastric cancer invasion and metastasis,
further affect prognosis.
A functional haplotype block composed of rs11099592 and
rs4693608 was found in our results, which was associated with
Borrmann type, pN category and prognosis of gastric cancer. On
the one hand, SNP rs11099592 is an A-G substitution nonsynon-
ymous SNP located in exon 8 and this alteration results in an
arginine-to-lysine replacement at position 307, perhaps leading to
a functional difference in the protein. On the other hand, SNP
rs4693608 is located in intron 3 and showed a correlation to
survival. Increasing amounts of evidence indicates that genomic
variants in non-coding sequences might alter the expression of
gene products by changing gene regulation, exon splicing, mRNA
stability, cryptic splice sites activation and so on, which can
Table 3. Associations between haplotype frequencies of the six SNPs in HPSE and clinicopathological parameters (n=404).
Block1 Block2
GC AG AC overall CA TG CG overall
Borrmann type
Borr1+2 0.822 0.154 0.023 0.769 0.125 0.106
Borr3+4 0.853 0.122 0.025 0.834 0.099 0.067
P* 0.445 0.377 0.895 0.673 0.037
# 0.29 0.076 0.095
Histologic grade
Well 0.839 0.122 0.039 0.800 0.116 0.084
Poor 0.846 0.134 0.020 0.822 0.103 0.075
P* 0.579 0.975 0.144 0.343 0.430 0.544 0.659 0.731
pT category
T1 0.789 0.175 0.035 0.763 0.136 0.102
T2 0.873 0.112 0.015 0.807 0.121 0.071
T3 0.841 0.126 0.033 0.824 0.097 0.079
T4 0.864 0.130 0.006 0.848 0.091 0.061
P* 0.363 0.575 0.344 0.539 0.069 0.160 0.329 0.189
pN category
N0 0.795 0.176 0.029 0.808 0.096 0.096
N1 0.894 0.074 0.032 0.796 0.092 0.112
N2 0.855 0.122 0.023 0.809 0.118 0.073
N3 0.864 0.117 0.019 0.835 0.114 0.051
P* 0.108 0.158 0.444 0.272 0.445 0.427 0.045
# 0.114
Venous invasion
Negative 0.845 0.131 0.025 0.815 0.107 0.078
Positive 0.833 0.167 0.000 1.00 0.000 0.000
P* 0.464 0.340 0.674 0.586 0.181 0.327 0.423 0.409
Lymphovascular invasion
Negative 0.826 0.141 0.026 0.821 0.096 0.076
Positive 0.879 0.101 0.020 0.785 0.135 0.080
P* 0.090 0.101 0.663 0.232 0.187 0.125 0.872 0.293
TNM stage
I 0.829 0.146 0.024 0.806 0.100 0.094
II 0.822 0.139 0.038 0.792 0.108 0.099
III 0.862 0.121 0.017 0.833 0.107 0.059
P* 0.267 0.443 0.320 0.451 0.259 0.873 0.076 0.207
*Two-sided x
2 test, each haplotype compared with all other haplotypes.
#Statistically significant (P,0.05).
doi:10.1371/journal.pone.0030277.t003
Polymorphisms and Gastric Cancer
PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e30277therefore cause disease phenotypes. Besides, haplotypes may
provide more relevant information than individual SNPs [7,41].
Furthermore, whether gene transcription, maintaining of cellular
differentiation and induction of an invasive metastatic phenotype
are due to the direct interaction of heparanase with DNA is yet to
be demonstrated.
Ostrovsky et al. [22] showed important association between
combined genotypes for rs4693608 and rs4364254 SNPs and
heparanase mRNA expression level. Furthermore, they divided all
combined genotypes into three subgroups (LR-low expression,
MR-intermediate expression, HR-high expression) according to
heparanase mRNA expression level of each genotype, and they
confirmed significant differences between three subgroups of
combined genotypes carriers and mRNA levels. Besides, Os-
trovsky et al. [37] first found correlations between combined
genotypes for rs4693608 and rs4364254 SNPs and risk of acute
GVHD development in their following study with this subgroups
analysis method. It is an important and valuable method.
Moreover, this method is useful for risk prediction associated with
haplotype approach in following clinical practice. Our future
study, which connected mRNA expression level to genotypes or
haplotypes in HPSE of the Han population in northern China,
would use this method.
Because the sample size of wild-type homozygote was relatively
too small for stratified analysis on each genotype of all six SNPs
investigated in our study, we could not show results of SNP
analysis on each genotype, but we carried out analysis combined
heterozygote with wild-type homozygote. It was a limitation of this
study.
In conclusion, this study evaluated polymorphisms of the HPSE
gene in gastric cancer with a MALDI-TOF MS method and
archived FFPETs in a large northern Chinese case-controlled
cohort. We found a functional haplotype block composed of
rs11099592 and rs4693608, which was associated with Borrmann
type, pN category and prognosis; and SNP rs4693608, which was
included in the block, showed a correlation to survival. These
results are supported by associations between SNPs in HPSE and
mRNA expression levels reported previously by Ostrovsky et al.
[22]. In addition, six individual SNPs and haplotypes were not
correlated to gastric cancer risk. These results were consistent with
our initial assumption that heparanase was involved in cancer
invasion and metastasis and affected prognosis ultimately, but it
was not involved in the incidence of cancer.
Materials and Methods
Sample collection
404 patients with histopathologically confirmed gastric cancer
who had received radical surgery between January 1998 and
December 2004 were consecutively selected. The patients were
from northern China and were believed to be good representatives
from this region. 404 normal gastric tissue samples were obtained
from a segment of the resected specimens farthest from the tumor
(.10 cm) and FFPETs were archived in the Surgical Oncology
Department of the First Hospital of China Medical University in
northern China. All samples were fixed and embedded under
standard clinical histological conditions and were stored at room
temperature. Paraffin sections of FFPETs were stained with
hematoxylin and eosin (H&E) for pathological inspection to
confirm the absence of tumorous tissue. The tumor histological
grade was assessed according to World Health Organization
criteria and tumors were staged using the 7th edition of the TNM
staging of the International Union Against Cancer (UICC)/
American Joint Committee on Cancer (AJCC) system (2010) based
on postoperative pathologic examination of the specimens.
Complete pathological data were obtained including age, gender,
date of surgery, location of the primary tumor, histologic grade,
venous invasion, lymphovascular invasion, depth of invasion,
number of LNs retrieved, number of metastatic LNs, and number
of tumor deposits retrieved. Those (i) with synchronous or
metachronous malignant tumors, (ii) with distant metastasis found
preoperatively, (iii) who underwent preoperative radiotherapy or
chemotherapy, or (iv) with incomplete pathological data entries
were excluded from this study. Follow-up was completed for the
entire study population by January 2010. Two patients died in the
postoperative period and 21 patients were lost during follow-up,
therefore 381 patients were included in survival analysis. Median
and mean follow-up periods were 90.0 months and 93.3620.24
months (range: 61–136 months), respectively. The following data
were obtained for all patients: date of death (if applicable), cause of
death (if applicable), and date of follow-up. The primary endpoint
was cause-specific survival duration from the date of gastric cancer
diagnosis to the date of death. The 5-year survival rate of the 404
patients was 54.2%.
404 blood samples were obtained from cancer-free individuals
who were randomly selected based on physical examinations
during December 2009 to August 2011, as the control group, and
this group was believed to be a good representation of the
population in northern China region. The selection criteria
included no individual history of cancer, frequency matching to
cases on sex and age and individuals were unrelated ethnic Han
Chinese. The samples (Ethylene Diamine Tetraacetic Acid
[EDTA] anticoagulate) were stored at 220uC within 30–
40 minutes, and then moved to a freezer at 280uC within 2 or
3 days after collection.
The study was approved by the Research Ethics Committee of
China Medical University, China. Written informed consents were
obtained from all patients before participating in the study.
DNA extraction
Genomic DNA was extracted from FFPET samples in the case
group. Sections with a thickness of 8 mm and a surface area of up
to 250 mm
2 were prepared with a microtome and DNA was
isolated from 6 to 12 sections, depending on the tissue size and cell
counts. The microtome was cleaned and blades were changed to
avoid intersample contamination. DNA extraction from FFPETs
was performed with QIAampH DNA FFPE Tissue Kit (Qiagen,
Hilden, Germany) [29], following the procedures described by the
Table 4. Survival analysis of haplotypes of the six SNPs in
HPSE (n=381).
Frequencies HR(95%CI) P*
Block1
GC 0.846 1
AG 0.022 0.847(0.627–1.146) 0.281
AC 0.132 0.676(0.299–1.528) 0.346
Block2
CA 0.823 1
TG 0.101 0.830(0.576–1.196) 0.317
CG 0.077 0.645(0.421–0.989) 0.044
*Based on Cox proportional hazards survival regression in haplotype-based
association analysis using the Stochastic-EM algorithm.
Abbreviation: HR, hazard rate; CI, confidence interval.
doi:10.1371/journal.pone.0030277.t004
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(ii) lyse sample under denaturing conditions with proteinase K, (iii)
reverse the formalin crosslinking incubation at 90uC, (iv) bind
DNA to the membrane and allow contaminants to flow through,
(v) wash residual contaminants, and (vi) elute pure and
concentrated DNA from the membrane (with tris-EDTA buffer
[TE]). About 2–10 mg of DNA was recovered in 50 ml final
solution and was stored at 280uC.
Genomic DNA was extracted from blood samples from the control
group with the Universal Genomic DNA Extraction Kit Ver.3.0
(TAKARA) according to the manufacturer’s instructions. About 2–
6 mg of DNA was recovered in TE and was stored at 280uC.
Selection of SNPs and genotyping
The study included six SNPs in HPSE, which were taken from
the NCBI SNPs database (http://www.ncbi.nlm.nih.gov/snp) and
the HapMap database (the Phase III database) (http://hapmap.
ncbi.nlm.nih.gov/index.html.zh). These SNPs were mapped in
HPSE gene (Figure 2). rs 11099592 was unique, not only with a
minor allele frequency (MAF).1%, but also as polymorphic in
Han China Beijing (HCB) population among all coding region
SNPs (cSNPs) in HPSE, which was registered in the databases. In
addition, other five SNPs were located in intronic and 39-UTR
regions. Furthermore, other investigators have shown that
rs11099592, rs4693608, and rs4364254 were correlated with
heparanase mRNA expression [22]. Also, associations between
individual SNPs or haplotypes in HPSE and susceptibility,
clinicopathological parameters and prognosis of tumor reported
in these articles was complex, but mostly concentrated on the six
SNPs we selected [17–22].
SNPs were genotyped using the MALDI-TOF MS system
(MassARRAY; Sequenom, San Diego, CA,USA) with primers and
probes (Table S6) as previously described [29,42]. To ensure the
typing quality, 1% positive samples (YanHuang cell strain) were
incorporated into every genotyping plate to validate the reliability
of the primers and 1% negative samples (water with no DNA) to
monitor contamination. 5% random samples were tested in
duplicate by different persons and the reproducibility was 100%.
The laboratory personnel were blinded to the sample arrangement
during the process. There were six steps including PCR
amplification, shrimp alkaline phosphatase treatment, base
extension, salt removal with resin, SpectroCHIP dispensing
(Sequenom, San Diego, CA,USA), and data acquisitions with
MALDI-TOF MS according to Justenhoven et al. [43]. Finally,
data analysis was performed using MassArray Typer Analyzer
software 4.0.4.20 (Sequenom, San Diego, CA) [44].
LD block determination and haplotype construction
Haploview 4.2 software was used to evaluate LD and construct
haplotypes [31]. LD between the six SNPs used in haplotype
analysis was measuredby a pairwiseD’ statistic. The structure ofthe
LD block was examined using the method of Gabriel et al. [45],
using the 80% confidence bounds of D’ to define sites of historical
recombination between SNPs. Haplotypes were constructed from
genotype data in the full-size case-control panel within blocks by
using an accelerated expectation-maximization algorithm method
[46]. Briefly, this method creates highly accurate population
frequency estimates of the phased haplotypes based on the
maximum likelihood as determined from unphased input [47].
Statistical analysis
Statistical analysis was undertaken using the PASW Statistics
18.0 software (SPSS, Inc., Somers, NY, USA). A two-sided chi-
square (x2) test was used to estimate population distribution
characteristics, compare differences in allelic and genotypic
frequencies between cases and controls and assess associations
between individual SNPs and clinicopathological parameters. A
permutation procedure (1,000 tests) was used to correct the P value
of single-locus association results. Odds ratios (OR) and confidence
intervals (CI; 95%) were calculated by unconditional logistic
regression to analyze the association between genotype frequencies
and gastric cancer risk, and were adjusted for sex and age.
Univariate and multivariate survival analysis were done with the
log-rank test and Cox proportional hazards model using the
clinicopathological parameters and SNPs. This resulted in the
identification of covariates that significantly correlated with
survival of the patients. Multivariate survival analysis was carried
out by separately adding the SNP variables to all the clinicopath-
ological parameters. A Kaplan-Meier method was used to map
survival curves. The Haploview 4.2 software package was used to:
estimate pair-wise linkage disequilibrium (LD), detect departure
from the Hardy–Weinberg equilibrium, construct haplotype and
calculate haplotype frequencies and estimate associations between
haplotypes and gastric cancer risk. The Haplo.states software was
used to assess associations between haplotypes and clinicopatho-
logic features [31]. The THEsias software based on Cox
proportional hazards survival regression in haplotype-based
association analysis using the Stochastic-EM algorithm was used
to produce survival analysis of haplotypes [48]. All tests were two-
tailed and P,0.05 was considered statistically significant.
Supporting Information
Figure S1 Representative MALDI-TOF-MS profiles of
each genotype of the six SNPs in HPSE.
(TIF)
Figure S2 Kaplan-Meier survival curve analysis with
the different genotypes of rs4693602, rs6856901,
rs4364254, rs11099592 and rs4328905. Results show that
accumulative survival rate of 381 cases with gastric cancer were
associated with the different genotypes of rs4693602, rs6856901,
rs4364254, rs11099592, and rs4328905 in HPSE.
(TIF)
Table S1 Genotyping success rates of the six SNPs in
HPSE.
(DOC)
Table S2 Associations between allele frequencies of the
six SNPs in HPSE and the risk of gastric cancer (n=404
for both case and control groups).
(DOC)
Table S3 Associations between genotype distributions
of the six SNPs in HPSE and the risk of gastric cancer
(n=404 for both case and control groups).
(DOC)
Table S4 Associations between genotype distributions
of the six SNPs in HPSE and clinicopathological
parameters (n=404).
(DOC)
Table S5 Associations between haplotype frequencies of
the six SNPs in HPSE and the risk of gastric cancer
(n=404 for both case and control groups).
(DOC)
Table S6 Primer sequences used for genotyping the six
SNPs in HPSE with the Sequenom platform.
(DOC)
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